Vizag Chemists Warn of 30, 40% Drug Price Surge

Pharmaceutical distributors in Visakhapatnam are warning that medicine prices could rise 30, 40% as the conflict involving Iran disrupts raw material supply chains feeding India's drug manufacturing sector. The alert covers generic and essential medicines, with paracetamol cited as a likely early casualty of the cost pressure. Current inventory remains unaffected, but distributors signal the strain will surface once existing stock cycles out. India sources a significant share of active pharmaceutical ingredients from West Asia, and supply disruption there flows directly into manufacturer input costs. When raw material costs rise sharply, manufacturers typically pass increases downstream to distributors and, ultimately, retail chemists. The Indian government has indicated it is taking steps to stabilize costs and ensure drug availability, though no specific policy instrument or price control measure was detailed. The situation warrants close attention from hospital procurement teams and retail pharmacy operators, as generic drug margins and patient out-of-pocket costs both face near-term pressure if the conflict persists.